He et al. [8] found that the XPC Lys939Gln polymorphism was significantly associated with overall cancer risk from 62 studies with a total of 25708 cancer cases and 30432 controls, they also found the Ala499Val polymorphism was associated with overall cancer risk with evidence from 34 studies including 14877 cases and 17888 controls. Here, XPC is linked to cancer.